Cara Care announced a $7M equity financing round today led by family-owned international food and nutrition manufacturer Dr. Schär AG, alongside existing investors Sabadell Asabys and Johnson & Johns...
ENDRA and CDTI Innvierte lead the new investment bringing up to €7million the total funds raised by the company in the last year, together with current investors Sabadell Asabys, Caixa Capital Risc ...
Dialogue with investors is no easy task for entrepreneurs in the healthcare sector. We will focus more on how to negotiate a round in the health Venture Capital investor sector in this article, and...
Libera Bio has announced that it has closed its Seed Round to advance its MPN Technology® into enabling studies and towards the clinic. Investors include Xesgalicia, Semola Tech Ventures, ROSP Co...
Eva Pando, presidenta de Sociedad Regional de Promoción, ha declarado que “Desde el principio confiamos en el gran equipo humano de Nanovex Biotechnologies y en su capacidad de ejecución. No solo ...
AtG Therapeutics is a recently created spin-off from IDIBELL and ICO, announces its launch with a first round of financing collecting 556,000 euros, received the support of international and national ...
BIOHUB VLC ha presentado su primer vehículo de inversión, BIOZELL VENTURES, en la Asamblea Anual de BIGBAN, la asociación nacional de inversores privados en startups, y que comenzará sus operacion...
Grow Venture Partners, la nueva gestora de Venture Capital con sede en Barcelona, que cerró un primer fondo sobreescrito de 5M€ y que tuvo que ampliarlo a 7M, tiene el objetivo de invertir en 10 pr...
SparingVision, a genomic medicine company developing vision-saving treatments for ocular diseases, today announces that it has raised €75 million in a Series B financing. The round was co-led by Jei...
El anticuerpo desarrollado por la empresa compostelana es la primera molécula licenciada por Ellipses Pharma en España y ha sido desarrollado en Galicia durante los últimos años. Para la consecuci...
The final closing of the Seed round consistsof € 1M investmentby i&i Biotech Fund I (i&i Bio), an early-stage Life Science fund with teams in Luxemburg and Prague which is backed by the European Inv...
Biozell Ventures, sociedad de coinversión enfocada en startups y scaleups de biotecnología, farmacia y salud, ha iniciado su actividad participando en la ronda de inversión de NUUBO con 270.000€,...